Literature DB >> 23108544

Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids.

Emma Puighermanal1, Arnau Busquets-Garcia, Rafael Maldonado, Andrés Ozaita.   

Abstract

Exogenous cannabinoids, such as delta9-tetrahydrocannabinol (THC), as well as the modulation of endogenous cannabinoids, affect cognitive function through the activation of cannabinoid receptors. Indeed, these compounds modulate a number of signalling pathways critically implicated in the deleterious effect of cannabinoids on learning and memory. Thus, the involvement of the mammalian target of rapamycin pathway and extracellular signal-regulated kinases, together with their consequent regulation of cellular processes such as protein translation, play a critical role in the amnesic-like effects of cannabinoids. In this study, we summarize the cellular and molecular mechanisms reported in the modulation of cognitive function by the endocannabinoid system.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23108544      PMCID: PMC3481526          DOI: 10.1098/rstb.2011.0384

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  126 in total

1.  Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations.

Authors:  N Hájos; I Katona; S S Naiem; K MacKie; C Ledent; I Mody; T F Freund
Journal:  Eur J Neurosci       Date:  2000-09       Impact factor: 3.386

2.  Molecular composition of the endocannabinoid system at glutamatergic synapses.

Authors:  István Katona; Gabriella M Urbán; Matthew Wallace; Catherine Ledent; Kwang-Mook Jung; Daniele Piomelli; Ken Mackie; Tamás F Freund
Journal:  J Neurosci       Date:  2006-05-24       Impact factor: 6.167

3.  Differential role of the hippocampal endocannabinoid system in the memory consolidation and retrieval mechanisms.

Authors:  Lucas De Oliveira Alvares; Bruna Pasqualini Genro; Felipe Diehl; Jorge A Quillfeldt
Journal:  Neurobiol Learn Mem       Date:  2008-03-14       Impact factor: 2.877

Review 4.  Endocannabinoid-mediated control of synaptic transmission.

Authors:  Masanobu Kano; Takako Ohno-Shosaku; Yuki Hashimotodani; Motokazu Uchigashima; Masahiko Watanabe
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

Review 5.  Functionally selective cannabinoid receptor signalling: therapeutic implications and opportunities.

Authors:  Barbara Bosier; Giulio G Muccioli; Emmanuel Hermans; Didier M Lambert
Journal:  Biochem Pharmacol       Date:  2010-03-03       Impact factor: 5.858

6.  Anti-ischemic and cognition-enhancing properties of NNC-711, a gamma-aminobutyric acid reuptake inhibitor.

Authors:  A W O'Connell; G B Fox; C Kjøller; H C Gallagher; K J Murphy; J Kelly; C M Regan
Journal:  Eur J Pharmacol       Date:  2001-07-13       Impact factor: 4.432

7.  Intracerebral microinjections of delta 9-tetrahydrocannabinol: search for the impairment of spatial memory in the eight-arm radial maze in rats.

Authors:  Nobuaki Egashira; Kenichi Mishima; Katsunori Iwasaki; Michihiro Fujiwara
Journal:  Brain Res       Date:  2002-10-18       Impact factor: 3.252

Review 8.  Role of endogenous cannabinoids in synaptic signaling.

Authors:  Tamas F Freund; Istvan Katona; Daniele Piomelli
Journal:  Physiol Rev       Date:  2003-07       Impact factor: 37.312

9.  Effects of hippocampal administration of a cannabinoid receptor agonist WIN 55,212-2 on spontaneous object and place recognition in rats.

Authors:  Toshiko Suenaga; Yukio Ichitani
Journal:  Behav Brain Res       Date:  2008-03-10       Impact factor: 3.332

10.  Effects of endocannabinoid system modulation on cognitive and emotional behavior.

Authors:  Claudio Zanettini; Leigh V Panlilio; Mano Alicki; Steven R Goldberg; József Haller; Sevil Yasar
Journal:  Front Behav Neurosci       Date:  2011-09-13       Impact factor: 3.558

View more
  33 in total

Review 1.  Endocannabinoid signalling in reward and addiction.

Authors:  Loren H Parsons; Yasmin L Hurd
Journal:  Nat Rev Neurosci       Date:  2015-09-16       Impact factor: 34.870

2.  CB1 receptor-mediated signaling underlies the hippocampal synaptic, learning, and memory deficits following treatment with JWH-081, a new component of spice/K2 preparations.

Authors:  Balapal S Basavarajappa; Shivakumar Subbanna
Journal:  Hippocampus       Date:  2014-02       Impact factor: 3.899

3.  Rapamycin inhibits mTOR/p70S6K activation in CA3 region of the hippocampus of the rat and impairs long term memory.

Authors:  D Lana; J Di Russo; T Mello; G L Wenk; M G Giovannini
Journal:  Neurobiol Learn Mem       Date:  2016-11-10       Impact factor: 2.877

Review 4.  New approaches and challenges to targeting the endocannabinoid system.

Authors:  Vincenzo Di Marzo
Journal:  Nat Rev Drug Discov       Date:  2018-08-17       Impact factor: 84.694

5.  A chronic low dose of Δ9-tetrahydrocannabinol (THC) restores cognitive function in old mice.

Authors:  Andras Bilkei-Gorzo; Onder Albayram; Astrid Draffehn; Kerstin Michel; Anastasia Piyanova; Hannah Oppenheimer; Mona Dvir-Ginzberg; Ildiko Rácz; Thomas Ulas; Sophie Imbeault; Itai Bab; Joachim L Schultze; Andreas Zimmer
Journal:  Nat Med       Date:  2017-05-08       Impact factor: 53.440

6.  Hippocampal Protein Kinase C Signaling Mediates the Short-Term Memory Impairment Induced by Delta9-Tetrahydrocannabinol.

Authors:  Arnau Busquets-Garcia; Maria Gomis-González; Victòria Salgado-Mendialdúa; Lorena Galera-López; Emma Puighermanal; Elena Martín-García; Rafael Maldonado; Andrés Ozaita
Journal:  Neuropsychopharmacology       Date:  2017-08-17       Impact factor: 7.853

7.  Lack of hippocampal CB1 receptor desensitization by Δ(9)-tetrahydrocannabinol in aged mice and by low doses of JZL 184.

Authors:  Monika Feliszek; Laura Bindila; Beat Lutz; Andreas Zimmer; Andras Bilkei-Gorzo; Eberhard Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-03-17       Impact factor: 3.000

8.  Cannabis Abusers Show Hypofrontality and Blunted Brain Responses to a Stimulant Challenge in Females but not in Males.

Authors:  Corinde E Wiers; Ehsan Shokri-Kojori; Christopher T Wong; Anissa Abi-Dargham; Şükrü B Demiral; Dardo Tomasi; Gene-Jack Wang; Nora D Volkow
Journal:  Neuropsychopharmacology       Date:  2016-05-09       Impact factor: 7.853

9.  Targeting the endocannabinoid system in the treatment of fragile X syndrome.

Authors:  Arnau Busquets-Garcia; Maria Gomis-González; Thomas Guegan; Carmen Agustín-Pavón; Antoni Pastor; Susana Mato; Alberto Pérez-Samartín; Carlos Matute; Rafael de la Torre; Mara Dierssen; Rafael Maldonado; Andrés Ozaita
Journal:  Nat Med       Date:  2013-03-31       Impact factor: 53.440

10.  Endocannabinoids in nervous system health and disease: the big picture in a nutshell.

Authors:  Stephen D Skaper; Vincenzo Di Marzo
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-12-05       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.